Zhenfeng M. Chen - 30 Sep 2025 SCHEDULE 13G Report for CASI Pharmaceuticals, Inc. Ordinary Share (CASI)

Filing Manager
Zhenfeng M. Chen
Reporting Manager
Chen Zhenfeng
Security
CASI Pharmaceuticals, Inc. Ordinary Share
Symbol
CASI
Shares outstanding
20,505,782 shares
Disclosed Ownership
2,255,636 shares
Ownership
11%
Form type
SCHEDULE 13G
Filing time
26 Nov 2025, 16:05:26 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Quoteable Key Fact

"Zhenfeng M. Chen disclosed 11% ownership in CASI Pharmaceuticals, Inc. Ordinary Share (CASI) on 30 Sep 2025."

Quick Takeaways

  • Zhenfeng M. Chen filed SCHEDULE 13G for CASI Pharmaceuticals, Inc. Ordinary Share (CASI).
  • Disclosed ownership: 11%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 26 Nov 2025, 16:05.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Chen Zhenfeng 11% 2,255,636 2,255,636 0 /s/ Chen Zhenfeng Chen Zhenfeng
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .